Q32 Bio Inc. (QTTB)
NASDAQ
Closed
Aug 25, 2026
Day's Range
16.0652 wk Range
1.62Overview - QTTB - Q32 Bio Inc.
Key Statistics
Valuation
Enterprise Value
386.05M
P/E (Trailing)
‪5.09‬
P/E (Forward)
‪-10.55‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪9.06‬
Price / Book
‪3.66‬
EV / EBITDA
‪17.69‬
Profitability
Profit Margin
‪62.87%‬
Operating Margin
‪39.93%‬
Return on Assets
‪14.74%‬
Return on Equity
‪72.13%‬
Ownership
Shares Outstanding
29.76M
Float
14.47M
Short % of Shares Outstanding
‪14.32%‬
Held by Insiders
‪2.82%‬
Held by Institutions
‪76.26%‬
Price stats
Beta
‪-0.32‬
50-Day Avg
‪14.55‬
200-Day Avg
‪7.42‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Average price target
‪$ 41.00‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - QTTB - Q32 Bio Inc.
Peers - QTTB - Q32 Bio Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- QTTBNASDAQQ32 Bio Inc.485.83MMarket Cap+89.46%52-week change5.10P/E (Trailing)‪62.87%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt63.39BMarket Cap+30.55%52-week change39.65P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc32.12BMarket Cap-87.94%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE28.34BMarket Cap+7.12%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.52BMarket Cap+21.81%52-week change19.30P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.84BMarket Cap+39.72%52-week change-21.44P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.59BMarket Cap+11.71%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - QTTB - Q32 Bio Inc.
About
Q32 Bio Inc. is a clinical-stage biotechnology company that develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases. The company focuses on targeting potent regulators of both the adaptive and innate immune systems to re-balance immunity in conditions…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
